The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Gaviscon Oral Suspension 500mg/10ml Sodium Alginate 267mg/10ml Sodium Bicarbonate 160mg/10ml Calcium Carbonate



Reckitt Benckiser Ireland LtdPA0979/015/001

Main Information

Trade NameGaviscon Oral Suspension 500mg/10ml Sodium Alginate 267mg/10ml Sodium Bicarbonate 160mg/10ml Calcium Carbonate
Active SubstancesSodium bicarbonate
Calcium carbonate
Sodium alginate
Dosage FormOral suspension
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/015/001

Group Information

ATC CodeA02AX Antacids, other combinations
A02AX13 Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

Status

License statusAuthorised
Licence Issued03/05/1978
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back